ProteoNic and Genencor Sign Research Agreement

16-Jun-2009 - Netherlands

ProteoNic and Genencor, a Danisco Division, have signed a research agreement. As part of the contract, the two biotech companies will use ProteoNic’s UNic™ Toolbox to investigate Enzyme production for Genencor’s fungal Expression platforms. ProteoNic will support Genencor in applying the unique protein yield enhancement products.

Victor Schut, Proteonic CEO: “The enzyme market is focused on product quality and competitive pricing. Genencor is a leader in this market, and their decision to team with us to improve the cost structure of their production will allow us to prove our leadership in this field. It will also further substantiate our track record in the field of fungal production systems. This partnership will demonstrate the value of combining molecular biology expertise (mRNA optimization) with extensive experience in large-scale production process optimization.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances